%0 Journal Article
%T 晚期上皮性卵巢癌的药物治疗及进展<br>Drug Therapy and Progress in Advanced Epithelial Ovarian Cancer
%A 李焕焕
%A 张晓兰
%J Journal of Clinical Personalized Medicine
%P 39-46
%@ 2334-3443
%D 2024
%I Hans Publishing
%R 10.12677/JCPM.2024.31007
%X 近年来，可用于上皮性卵巢癌的治疗选择方式不断增加，在化疗的基础上，运用靶向治疗、免疫治疗，以进一步改善卵巢癌患者的预后、提高其生活的质量，就需要制订更加个体化的治疗策略。本文就上皮性卵巢癌化疗、靶向治疗、免疫治疗等方面进行综述，以期为临床提供更多帮助。<br />
In recent years, the treatment options for epithelial ovarian cancer are increasing. On the basis of chemotherapy, targeted therapy and immunotherapy are used to further improve the prognosis of ovarian cancer patients and improve their quality of life, so it is necessary to develop more individ-ualized treatment strategies. This article reviews the chemotherapy, targeted therapy and immu-notherapy of epithelial ovarian cancer, in order to provide more help for clinical practice.
%K 上皮性卵巢癌，化学治疗，靶向治疗，联合治疗<br>Epithelial Ovarian Cancer
%K Chemotherapy
%K Targeted Therapy
%K Combination Therapy
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=80723